Description
Description of Imatib 100 mg Cipla product characteristics
Imatib 100 mg Cipla, also known as Imatinib, is a targeted therapy medication primarily used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This oral medication functions by inhibiting specific proteins that promote cancer cell proliferation, offering a way to effectively manage these cancers. Imatib works by selectively blocking the activity of the BCR-ABL tyrosine kinase, a critical driver of tumor growth in CML.
The product is designed to be taken once daily, with or without food, ensuring convenience for patients. Each tablet contains 100 mg of the active ingredient, delivering a controlled dosage for effective treatment. Imatib is available in blister packaging and is usually prescribed following a thorough assessment by healthcare professionals. As a product of Cipla, a reputable pharmaceutical company, Imatib maintains stringent quality control standards.
Effect on endurance results of use
While Imatib 100 mg Cipla is not traditionally associated with enhancing athletic performance, its impact on endurance can be examined through a broader lens of health and fitness. The primary role of Imatib in cancer treatment can indirectly affect an athlete’s endurance by maintaining optimal health.
- Improved blood cell counts: By managing tumors, Imatib helps to stabilize the blood’s natural composition, potentially leading to better oxygen delivery during physical activities.
- Reduced fatigue: Successful treatment of cancer may alleviate fatigue in athletes, allowing for better endurance during training and competition.
- Risk management: By controlling cancer effectively, athletes can focus on training without the debilitating effects of untreated illness.
- Overall well-being: Maintaining a healthier body can lead to gradual improvements in stamina and performance.
It is worth noting that athletes using Imatib should consult with healthcare professionals to ensure they are within safe parameters for their competitive pursuits.
Side effects maximum safe dosage
As with any medication, Imatib 100 mg Cipla comes with potential side effects. Understanding these side effects is crucial for safe usage. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. More serious adverse effects can include liver problems, heart issues, and gastrointestinal bleeding.
Patients often experience mild symptoms at the beginning of treatment, which may subside over time. However, if severe side effects occur, it is vital to seek medical attention promptly. The maximum recommended dosage typically does not exceed 400 mg per day but should always align with a physician’s prescription based on individual health conditions.
Always monitor your body’s response while using Imatib. Keep a close communication line with healthcare professionals to report any unexpected reactions, ensuring proper adjustments are made to the treatment plan.
Where to buy Imatib 100 mg Cipla official store in English
Purchasing Imatib 100 mg Cipla requires caution to ensure product authenticity and safety. It is advisable to buy from reputable pharmacies and official online stores. The official Cipla website often provides resources and links to authorized distributors.
Before making any purchases:
- Verify the pharmacy’s credentials.
- Look for real customer reviews that affirm product authenticity.
- Ensure the online store requires a prescription, as this indicates a commitment to patient safety.
- Check for contact information and customer service accessibility in case of inquiries.
By following these guidelines, consumers can confidently purchase Imatib 100 mg Cipla without compromising safety or quality.
Practical recommendations
When considering Imatib 100 mg Cipla for health management, adhering to certain practical recommendations ensures maximum effectiveness and safety.
Firstly, always follow the prescribed dosage guidelines from medical professionals, avoiding self-medication. Secondly, maintain a balanced diet rich in vitamins and minerals to support overall health. This can enhance the medication’s efficacy and aid in recovery. Additionally, stay hydrated, as adequate fluid intake is essential when undergoing medication treatment.
Regular monitoring of health markers, such as blood cell levels, offers insights into how the body responds to the medication. Engaging in light physical activity, as approved by a healthcare provider, can help improve general well-being, as long as it does not lead to physical strain. Finally, keep a detailed log of any side effects and communicate these findings during follow-up consultations.
By staying informed and proactive, individuals using Imatib 100 mg Cipla can promote a smoother treatment experience while prioritizing their health and fitness goals.
Additional information
| Active substance | Imatinib |
|---|---|
| Water Retention | Yes, can cause fluid retention |
| Hepatotoxicity | Low, but liver function tests are recommended |
| Lab Test | Monitoring of complete blood counts and liver function tests are advised |
| Strength | 100mg |
| Also known as | STI571 |
| Blood pressure | Can cause changes in blood pressure, monitoring advised |
| Trade name | Gleevec (USA), Glivec (Europe and Australia) |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide |
| Formula | C29H31N7O |
| Substance class | Tyrosine kinase inhibitor |
| Main action | Inhibits the Bcr-Abl tyrosine kinase |
| Half-life | Approximately 18 hours |
| Dosage (medical) | Typically 400-800 mg per day, depending on the condition being treated |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Treats certain types of cancer by blocking the action of the abnormal protein that signals cancer cells to multiply |
| Side effects | Nausea, vomiting, edema, muscle cramps, musculoskeletal pain, diarrhea, rash, fatigue, abdominal pain |
| Use in sports | None, not used as a performance-enhancing drug |
| Manufacturer | Cipla Ltd. |
| Packing | 10 tabs/blister |
Related products
-

Forcan 150 mg Cipla
0 out of 5€16.00 Add to cart -


Qutipin 300 mg Sun Pharmaceuticals Industries
0 out of 5€48.00 Add to cart -


Loratin 10 mg Cipla
0 out of 5€14.00 Add to cart -

Tudca 500 mg Allaes
0 out of 5Select options This product has multiple variants. The options may be chosen on the product page




Reviews
There are no reviews yet.